Fifth Third Bancorp Raises Stock Position in Regeneron Pharmaceuticals, Inc. $REGN

2026-02-23 09:29:20

Fifth Third Bancorp increased its stake in Regeneron Pharmaceuticals, Inc. by 19.0% during the third quarter, bringing its total holdings to 12,063 shares valued at $6.78 million. Regeneron recently surpassed analyst earnings estimates, reporting $11.44 EPS versus $10.74 expected, and the company has also raised its quarterly dividend. Institutional investors hold a significant 83.31% of the biopharmaceutical company’s stock, while insiders have sold shares totaling approximately $2.86 million in the last quarter.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes